NEVANAC Side Effects

6971328-6 | Condition Aggravated, Corneal Oedema, Eye Irritation, Visual Acuity Reduced
on Aug 27, 2010 Male patient from UNITED STATES , weighting 152.0 lb, was diagnosed with retinal oedema and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, corneal oedema, eye irritation, visual acuity reduced. Nevanac dosage: 1 Gtt Tid Od Ophthalmic. During the same period patient was treated with PRED FORTE (View Pred Forte Review and Pred Forte Label ), TIMOPTIC (View Timoptic Review and Timoptic Label ), BRIMONIDINE (View Brimonidine Review and Brimonidine Label ), ARTIFICIAL TEARS (View Artificial Tears Review and Artificial Tears Label ), PROZAC (View Prozac Review and Prozac Label ), POTASSIUM (View Potassium Review and Potassium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6931129-1 | Convulsion, Cough, Muscle Spasms, Pruritus, Throat Irritation
Patient was taking Nevanac (View Usage). Patient had the following side effects: convulsion, cough, muscle spasms, pruritus, throat irritation on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , 78 years of age, weighting 170.0 lb, was diagnosed with cataract operation, eye laser surgery and. Nevanac dosage: .

6874741-0 | Condition Aggravated, Hypoaesthesia Oral, Vision Blurred, Visual Acuity Reduced, Wheezing
Adverse event was reported on Jun 29, 2010 by a Female patient taking Nevanac (View Usage) (Dosage: 3 Gtt Os Ophthalmic, 1 Gtt Tid Os Ophthalmic , Bid Ophthalmic) was diagnosed with cataract operation and. Location: UNITED STATES , weighting 170.0 lb, After Nevanac was administered, patient had the following side effects: condition aggravated, hypoaesthesia oral, vision blurred, visual acuity reduced, wheezing. During the same period patient was treated with OMNIPRED (3 Gtt Tid Os Ophthalmic, Bid Ophthalmic, 1 Gtt Tid Os Ophthalmic) (View Omnipred Review and Omnipred Label ), VIGAMOX (3 Gtt Os Ophthalmic, 1 Gtt Tid Ou Ophthalmic) (View Vigamox Review and Vigamox Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), HYDROCHOLORTHIAZIDE (View Hydrocholorthiazide Review and Hydrocholorthiazide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VALIUM (View Valium Review and Valium Label ).

6844397-1 | Condition Aggravated, Hypoaesthesia Oral, Vision Blurred, Visual Acuity Reduced, Wheezing
on Jun 29, 2010 Female patient from UNITED STATES , weighting 170.0 lb, was diagnosed with cataract operation and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, hypoaesthesia oral, vision blurred, visual acuity reduced, wheezing. Nevanac dosage: (3 Gtt Tid Os Ophthalmic), (1 Gtt Tid Os Ophthalmic), (bid Ophthalmic). During the same period patient was treated with OMNIPRED ((3 Gtt Tid Os Ophthalmic), (bid Ophthalmic), (1 Gtt Tid Os Ophthalmic)) (View Omnipred Review and Omnipred Label ), VIGAMOX ((3 Gtt Tid Os Ophthalmic), (1 Gtt Tid Ou Ophthalmic)) (View Vigamox Review and Vigamox Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).


6798843-2 | Anaphylactic Reaction
on Jun 09, 2010 Male patient from NETHERLANDS , 66 years of age, was treated with Nevanac (View Usage). Patient had the following side effects: anaphylactic reaction. Nevanac dosage: Ophthalmic. Patient was hospitalized.

6752721-3 | Cataract Operation Complication, Retinal Oedema, Visual Acuity Reduced
Patient was taking Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: cataract operation complication, retinal oedema, visual acuity reduced on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 160.0 lb, was diagnosed with cataract operation and. Nevanac dosage: (1 Ggt Ou Qid Ophthalmic), (1 Ggt Ou Qid Ophthalmic). During the same period patient was treated with OMNIPRED (See Image) (View Omnipred Review and Omnipred Label ).

6745177-8 | Bacterial Infection, Endophthalmitis, Hypopyon, Product Contamination Microbial
Adverse event was reported on May 14, 2010 by a Male patient taking Nevanac (View Usage) (Dosage: (ophthalmic)) was diagnosed with cataract operation and. Location: UNITED STATES , 89 years of age, Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), endophthalmitis, hypopyon, product contamination microbial.

6723349-6 | Corneal Infiltrates, Sensation Of Foreign Body, Vision Blurred
on Mar 29, 2010 Male patient from CANADA , 77 years of age, was diagnosed with preoperative care, postoperative care and was treated with Nevanac (View Usage). Patient had the following side effects: corneal infiltrates, sensation of foreign body, vision blurred. Nevanac dosage: Qid, Qid, Ophthalmic, Ophthalmic. During the same period patient was treated with VIGAMOX (Qid, Qid, Ophthalmic, Ophthalmic) (View Vigamox Review and Vigamox Label ), PRED FORTE (View Pred Forte Review and Pred Forte Label ), COMBIGAN (COMBIGAN) (View Combigan (combigan) Review and Combigan (combigan) Label ).

6717890-X | Retinal Oedema, Visual Acuity Reduced
on Apr 20, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with cataract operation and was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: retinal oedema, visual acuity reduced. Nevanac dosage: (1 Gtt Ou Qid Ophthalmic) ; (1 Gtt Ou Qid Ophthalmic). During the same period patient was treated with OMNIPRED (See Image) (View Omnipred Review and Omnipred Label ).

6699504-0 | Headache, Migraine, Nausea, Transient Ischaemic Attack
Patient was taking Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), migraine (What is migraine?), nausea (What is nausea?), transient ischaemic attack on Apr 27, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with retinal vascular occlusion and. Nevanac dosage: 1 Drop 4 Times/day Ophthalmic. Patient was hospitalized.

6687274-1 | Burning Sensation, Chills, Dry Mouth, Dry Skin, Gastrointestinal Motility Disorder, Oral Pain, Paraesthesia, Pruritus, Vision Blurred
Adverse event was reported on Apr 01, 2010 by a Female patient taking Nevanac (View Usage) (Dosage: (1 Gtt Tid X One Week Ophthalmic)) was diagnosed with intraocular pressure increased, postoperative care and. Location: UNITED STATES , weighting 169.0 lb, Patient had the following side effects: burning sensation, chills, dry mouth, dry skin, gastrointestinal motility disorder, oral pain, paraesthesia, pruritus, vision blurred. During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ), BRIMONIDINE (View Brimonidine Review and Brimonidine Label ), AZOPT (View Azopt Review and Azopt Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), DIAMOX SRC (View Diamox Src Review and Diamox Src Label ).

6648503-3 | Corneal Opacity, Eye Pain, Impaired Healing, Keratitis, Ocular Discomfort, Photophobia, Visual Acuity Reduced
on Mar 08, 2010 Female patient from UNITED STATES , 23 years of age, weighting 110.0 lb, was diagnosed with photorefractive keratectomy and was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: corneal opacity, eye pain, impaired healing, keratitis, ocular discomfort, photophobia, visual acuity reduced. Nevanac dosage: Qid Ophthalmic. During the same period patient was treated with OMNIPRED (View Omnipred Review and Omnipred Label ), VIGAMOX (View Vigamox Review and Vigamox Label ), SYSTANE (View Systane Review and Systane Label ).

6633037-2 | Corneal Opacity, Eye Pain, Impaired Healing, Photophobia
on Feb 23, 2010 Female patient from UNITED STATES , 23 years of age, was diagnosed with photorefractive keratectomy and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: corneal opacity, eye pain, impaired healing, photophobia. Nevanac dosage: (ophthalmic). During the same period patient was treated with OMNIPRED (View Omnipred Review and Omnipred Label ), VIGAMOX (View Vigamox Review and Vigamox Label ).

6509526-8 | Dry Mouth, Fatigue, Headache, Transient Ischaemic Attack
Patient was taking Nevanac (View Usage). Patient had the following side effects: dry mouth, fatigue, headache (What is headache?), transient ischaemic attack on Dec 04, 2009 from NETHERLANDS Additional patient health information: Female patient , 68 years of age, was diagnosed with cataract operation and. Nevanac dosage: 1 Gtt Tid. During the same period patient was treated with TOBRADEX (1 Gtt Qid) (View Tobradex Review and Tobradex Label ).

6488987-7 | Acanthamoeba Infection, Corneal Scar, Eye Infection Fungal, Photophobia, Staphylococcal Infection, Ulcerative Keratitis, Vasculitis
Adverse event was reported on Nov 20, 2009 by a Male patient taking Nevanac (View Usage) (Dosage: (q2h While Awake Ophthalmic) ; (ou Q 4 H While Awake Ophthalmic)) was diagnosed with prophylaxis and. Location: UNITED STATES , 35 years of age, After Nevanac was administered, patient had the following side effects: acanthamoeba infection, corneal scar, eye infection fungal, photophobia, staphylococcal infection (What is staphylococcal infection?), ulcerative keratitis, vasculitis (What is vasculitis?). During the same period patient was treated with TOBRADEX ((q2h While Awake Ophthalmic)) (View Tobradex Review and Tobradex Label ), PROPARACAINE HCL (View Proparacaine Hcl Review and Proparacaine Hcl Label ), VIGAMOX (View Vigamox Review and Vigamox Label ).

6428246-1 | Complications Of Transplant Surgery, Scleral Disorder
on Oct 19, 2009 Female patient from BRAZIL , 30 years of age, was diagnosed with postoperative care and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: complications of transplant surgery, scleral disorder. Nevanac dosage: 1 Gtt Bid Od Ophthalmic. During the same period patient was treated with FLORATE (FLUOROMETHOLONE ACETATE) (View Florate (fluorometholone Acetate) Review and Florate (fluorometholone Acetate) Label ), ZYMAR (View Zymar Review and Zymar Label ), SYSTANE (RHINARIS) (View Systane (rhinaris) Review and Systane (rhinaris) Label ), TENOXICAM (TENOXICAM) (View Tenoxicam (tenoxicam) Review and Tenoxicam (tenoxicam) Label ).

6375193-X | Abnormal Sensation In Eye, Apraxia, Diplopia, Extraocular Muscle Disorder, Eye Discharge, Eye Pain, Eye Pruritus, Eye Swelling, Foreign Body Sensation In Eyes
on Sep 08, 2009 Female patient from UNITED STATES , 79 years of age, was diagnosed with cataract operation and was treated with Nevanac (View Usage). Patient had the following side effects: abnormal sensation in eye, apraxia, diplopia, extraocular muscle disorder, eye discharge, eye pain, eye pruritus, eye swelling, foreign body sensation in eyes. Nevanac dosage: (1 Gtt Ou Qid Ophthalmic) ; (1 Gtt Ou Qid Ophthalmic).

6318454-2 | Abdominal Discomfort, Anaphylactic Reaction, Dyspnoea, Eye Pruritus, Heart Rate Increased, Lip Swelling, Sinusitis
Patient was taking Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: abdominal discomfort, anaphylactic reaction, dyspnoea, eye pruritus, heart rate increased, lip swelling, sinusitis (What is sinusitis?) on Aug 05, 2009 from UNITED STATES Additional patient health information: Female patient , 81 years of age, weighting 170.0 lb, was diagnosed with prophylaxis and. Nevanac dosage: 1 Gtt X 1 Ophthalmic.

6317225-0 | Anaphylactic Reaction, Sinusitis
Adverse event was reported on Aug 05, 2009 by a Female patient taking Nevanac (View Usage) (Dosage: 1 Gtt X 1 Ophthalmic) was diagnosed with prophylaxis and. Location: UNITED STATES , 79 years of age, weighting 170.0 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, sinusitis (What is sinusitis?).

6287578-0 | Corneal Oedema, Eye Irritation, Eye Swelling, Lacrimation Increased, Ocular Hyperaemia, Photophobia, Post Procedural Complication
on Jul 14, 2009 Female patient from UNITED STATES , 77 years of age, was diagnosed with eye swelling, prophylaxis and was treated with Nevanac (View Usage). Patient had the following side effects: corneal oedema, eye irritation, eye swelling, lacrimation increased, ocular hyperaemia, photophobia, post procedural complication. Nevanac dosage: 1 Gtt Od Qid Ophthalmic, 1 Gtt Od Qid Ophthalmic, 1 Gtt Od Bid Ophthalmic. During the same period patient was treated with OMNIPRED (View Omnipred Review and Omnipred Label ), DIFLUPREDNATE (View Difluprednate Review and Difluprednate Label ), VIGAMOX (View Vigamox Review and Vigamox Label ).

6268205-5 | Corneal Opacity, Corneal Scar, Glare, Halo Vision, Impaired Driving Ability, Ulcerative Keratitis
on Jul 14, 2009 Male patient from UNITED STATES , weighting 210.0 lb, was diagnosed with photorefractive keratectomy, procedural pain and was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: corneal opacity, corneal scar, glare, halo vision, impaired driving ability, ulcerative keratitis. Nevanac dosage: One Drop 3xday Ophthalmic.

6219556-1 | Apraxia, Diplopia, Eye Discharge, Eye Pain, Eye Pruritus, Eye Swelling, Eyelid Ptosis, Foreign Body Sensation In Eyes, Madarosis
Patient was taking Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: apraxia, diplopia, eye discharge, eye pain, eye pruritus, eye swelling, eyelid ptosis, foreign body sensation in eyes, madarosis on May 21, 2009 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with cataract operation and. Nevanac dosage: (1 Gtt Ou Qid Ophthalmic).

6216835-9 | Asthenopia, Eye Discharge, Eye Pruritus, Eye Swelling, Facial Palsy, Photophobia, Retinal Oedema, Vision Blurred
Adverse event was reported on Jun 03, 2009 by a Female patient taking Nevanac (View Usage) (Dosage: 1 Drop Each Eye 3 Times Day Eyes) was diagnosed with posterior capsule opacification, retinal oedema and. Location: UNITED STATES , weighting 186.0 lb, Patient had the following side effects: asthenopia, eye discharge, eye pruritus, eye swelling, facial palsy, photophobia, retinal oedema, vision blurred.

6182357-7 | Chest Discomfort, Chest Pain, Heart Rate Increased, Hypertension
on May 05, 2009 Female patient from UNITED STATES , 67 years of age, weighting 164.0 lb, was diagnosed with cataract operation, postoperative care and was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: chest discomfort, chest pain (What is chest pain?), heart rate increased, hypertension. Nevanac dosage: I Drop Os Tid Ophthalmic. Patient was hospitalized.

6125709-3 | Arthralgia, Headache, Hypertension, Sinusitis
on Mar 19, 2009 Female patient from UNITED STATES , 69 years of age, weighting 115.0 lb, was diagnosed with cataract (What is cataract?) and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, headache (What is headache?), hypertension, sinusitis (What is sinusitis?). Nevanac dosage: 1 Drop Four Times A Day Ophthalmic.

6063635-9 | Corneal Scar, Corneal Thinning, Eye Pain, Ocular Hyperaemia, Photophobia, Ulcerative Keratitis
Patient was taking Nevanac (View Usage). Patient had the following side effects: corneal scar, corneal thinning, eye pain, ocular hyperaemia, photophobia, ulcerative keratitis on Jan 19, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 250.0 lb, was diagnosed with cataract operation and. Nevanac dosage: 1 Gtt Tid Od Ophthalmic. During the same period patient was treated with PLAQUENIL (View Plaquenil Review and Plaquenil Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FOSAMAX (View Fosamax Review and Fosamax Label ).

5976448-0 | Bacillus Infection, Culture Positive, Laboratory Test Interference, Photophobia, Staphylococcal Infection, Ulcerative Keratitis
Adverse event was reported on Nov 17, 2008 by a Male patient taking Nevanac (View Usage) (Dosage: (ou Q 2 Hours X 3 Days Opthalmic), (ou Q 4 Hours X 2 Days Opthalmic)) was diagnosed with photorefractive keratectomy and. Location: UNITED STATES , 35 years of age, After Nevanac was administered, patient had the following side effects: bacillus infection, culture positive, laboratory test interference, photophobia, staphylococcal infection (What is staphylococcal infection?), ulcerative keratitis. During the same period patient was treated with TOBRADEX ((ou Q 2 Hours Opthalmic)) (View Tobradex Review and Tobradex Label ), VIGAMOX ((ou Q 2 Hours Opthalmic)) (View Vigamox Review and Vigamox Label ).

5897400-X | Dysgeusia, Weight Increased
on May 28, 2008 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with macular oedema, prophylaxis and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, weight increased. Nevanac dosage: See Image. During the same period patient was treated with ECONOPRED PLUS SUSPENSION ((ophthalmic)) (View Econopred Plus Suspension Review and Econopred Plus Suspension Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), DIOVAN (View Diovan Review and Diovan Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5820001-6 | Condition Aggravated, Haemorrhage, Post Procedural Haematoma, Pterygium, Scar
on Jul 18, 2008 Female patient from UNITED STATES , 47 years of age, weighting 180.0 lb, was diagnosed with keratitis, keratomileusis, pterygium and was treated with Nevanac (View Usage). Patient had the following side effects: condition aggravated, haemorrhage, post procedural haematoma, pterygium, scar (What is scar?). Nevanac dosage: .

5813684-8 | Acanthamoeba Infection, Autoimmune Disorder, Corneal Cyst, Corneal Disorder, Corneal Infiltrates, Corneal Perforation, Corneal Scar, Corneal Transplant, Culture Positive
Patient was taking Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: acanthamoeba infection, autoimmune disorder, corneal cyst, corneal disorder, corneal infiltrates, corneal perforation, corneal scar, corneal transplant, culture positive on Jun 27, 2008 from UNITED STATES Additional patient health information: Male patient , 34 years of age, was diagnosed with prophylaxis and. Nevanac dosage: (q2h Ophthalmic). During the same period patient was treated with TOBRADEX ((q2h Ophthalmic)) (View Tobradex Review and Tobradex Label ).

5794326-7 | Acanthamoeba Infection, Autoimmune Disorder, Culture Positive, Staphylococcal Infection, Ulcerative Keratitis
Adverse event was reported on Jun 03, 2008 by a Male patient taking Nevanac (View Usage) (Dosage: (q2h Ophthalmic)) was diagnosed with prophylaxis and. Location: UNITED STATES , 35 years of age, Patient experienced the following unwanted or unexpected effects: acanthamoeba infection, autoimmune disorder, culture positive, staphylococcal infection (What is staphylococcal infection?), ulcerative keratitis. During the same period patient was treated with TOBRADEX ((q2h Ophthalmic)) (View Tobradex Review and Tobradex Label ).

5717126-2 | Ulcerative Keratitis
on Apr 08, 2008 Female patient from UNITED STATES , 82 years of age, was diagnosed with macular oedema and was treated with Nevanac (View Usage). Patient had the following side effects: ulcerative keratitis. Nevanac dosage: 3 X Daily Ophthalmic. During the same period patient was treated with TRAVATAN (View Travatan Review and Travatan Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ).

5674266-4 | Madarosis
on Dec 05, 2007 Female patient from UNITED STATES , 80 years of age, was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: madarosis. Nevanac dosage: (ophthalmic).

5525367-2 | Blood Creatine Increased
Patient was taking Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine increased on Aug 15, 2007 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 138.0 lb, was diagnosed with chorioretinopathy, macular oedema and. Nevanac dosage: 1 Gtt Qid Ophthalmic. During the same period patient was treated with PRED FORTE (View Pred Forte Review and Pred Forte Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), DIAMOX (View Diamox Review and Diamox Label ), COSOPT (View Cosopt Review and Cosopt Label ), DACLIZUMAB (View Daclizumab Review and Daclizumab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5525365-9 | Asthenopia, Eye Pain, Headache
Adverse event was reported on Sep 04, 2007 by a Male patient taking Nevanac (View Usage) (Dosage: Ophthalmic) was diagnosed with eye pain, headache (What is headache?) and. Location: UNITED STATES , 67 years of age, weighting 185.0 lb, Patient had the following side effects: asthenopia, eye pain, headache (What is headache?). During the same period patient was treated with TRAVATAN (View Travatan Review and Travatan Label ), TOBRADEX (View Tobradex Review and Tobradex Label ), AVODART (View Avodart Review and Avodart Label ), ISTALOL (View Istalol Review and Istalol Label ), SYSTANE (View Systane Review and Systane Label ), NEXIUM (View Nexium Review and Nexium Label ), UROXATRAL (View Uroxatral Review and Uroxatral Label ).

5525364-7 | Dry Eye, Eye Irritation
on Sep 13, 2007 Female patient from UNITED STATES , 75 years of age, weighting 113.0 lb, was diagnosed with prophylaxis and was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: dry eye, eye irritation. Nevanac dosage: Ophthalmic. During the same period patient was treated with ECONOPRED PLUS (Ophthalmic) (View Econopred Plus Review and Econopred Plus Label ), NORVASC (View Norvasc Review and Norvasc Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), AVALIDE (View Avalide Review and Avalide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INDERAL (View Inderal Review and Inderal Label ).

5525346-5 | Visual Disturbance
on Sep 07, 2007 Female patient from UNITED STATES , 84 years of age, weighting 130.0 lb, was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: visual disturbance. Nevanac dosage: (ophthalmic).

5522915-3 | Corneal Transplant, Ulcerative Keratitis
Patient was taking Nevanac (View Usage). Patient had the following side effects: corneal transplant, ulcerative keratitis on Nov 07, 2007 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with prophylaxis and. Nevanac dosage: (opht Ophthalmic). During the same period patient was treated with ECONOPRED PLUS (View Econopred Plus Review and Econopred Plus Label ), VIGAMOX (View Vigamox Review and Vigamox Label ).

5477726-4 | Eye Oedema
Adverse event was reported on Sep 18, 2007 by a Male patient taking Nevanac (View Usage) (Dosage: One Drop To Eye 4 Times A Day) was diagnosed with cataract operation and. Location: UNITED STATES , 83 years of age, After Nevanac was administered, patient had the following side effects: eye oedema.

5463866-2 | Eye Inflammation, Lenticular Opacities, Maculopathy
on May 10, 2007 Female patient from UNITED STATES , 60 years of age, was diagnosed with prophylaxis and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: eye inflammation, lenticular opacities, maculopathy. Nevanac dosage: Ophthalmic.

5463023-X | Corneal Erosion, Corneal Oedema
on Sep 18, 2007 Male patient from UNITED STATES , 79 years of age, was treated with Nevanac (View Usage). Patient had the following side effects: corneal erosion, corneal oedema. Nevanac dosage: One Eye Drop 4 Times A Day.

5358487-6 | Conjunctival Scar, Hypersensitivity, Keratitis, Photophobia, Pyrexia, Visual Acuity Reduced
Patient was taking Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: conjunctival scar, hypersensitivity, keratitis, photophobia, pyrexia, visual acuity reduced on Feb 14, 2007 from UNITED STATES Additional patient health information: Male patient , 68 years of age, . Nevanac dosage: (ophthalmic).

5358477-3 | Condition Aggravated
Adverse event was reported on Feb 19, 2007 by a Female patient taking Nevanac (View Usage) (Dosage: (1 Gtt Gtts 1 Tid; Os Ophthalmic)) was diagnosed with macular oedema and. Location: UNITED STATES , 56 years of age, weighting 105.0 lb, Patient experienced the following unwanted or unexpected effects: condition aggravated.

5358471-2 | Asthenia, Blood Pressure Increased, Dizziness
on Mar 14, 2007 Female patient from UNITED STATES , 82 years of age, weighting 150.0 lb, was diagnosed with iritis and was treated with Nevanac (View Usage). Patient had the following side effects: asthenia, blood pressure increased, dizziness (What is dizziness?). Nevanac dosage: (i Gtt Ou Tid Prn Ophthalmic). During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), COZAAR (View Cozaar Review and Cozaar Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATIVAN (View Ativan Review and Ativan Label ).

5358470-0 | Anterior Chamber Cell, Corneal Oedema, Eye Pain, Keratitis, Ocular Discomfort
on Apr 16, 2007 Female patient from UNITED STATES , 75 years of age, weighting 117.0 lb, was diagnosed with prophylaxis and was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: anterior chamber cell, corneal oedema, eye pain, keratitis, ocular discomfort. Nevanac dosage: (ophthalmic). During the same period patient was treated with ECONOPRED (View Econopred Review and Econopred Label ).

5307740-0 | Bipolar Disorder, Blood Pressure Increased, Pyrexia, Refusal Of Treatment By Patient
Patient was taking Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: bipolar disorder (What is bipolar disorder?), blood pressure increased, pyrexia, refusal of treatment by patient on Apr 03, 2007 from UNITED STATES Additional patient health information: Female patient , 70 years of age, was diagnosed with surgery (What is surgery?) and. Nevanac dosage: (opthalmic) ;. During the same period patient was treated with SYSTANE (View Systane Review and Systane Label ), VIGAMOX (View Vigamox Review and Vigamox Label ), ECONOPRED (View Econopred Review and Econopred Label ).

5274955-X | Dizziness, Nausea
Adverse event was reported on Aug 21, 2006 by a Female patient taking Nevanac (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 61 years of age, weighting 190.0 lb, Patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?). During the same period patient was treated with VIGAMOX (View Vigamox Review and Vigamox Label ), THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ).

5274950-0 | Erythema, Weight Decreased
on Oct 02, 2006 Male patient from UNITED STATES , 87 years of age, weighting 180.0 lb, was diagnosed with prophylaxis and was treated with Nevanac (View Usage). After Nevanac was administered, patient had the following side effects: erythema, weight decreased. Nevanac dosage: 3 Gtt Qd Opht. During the same period patient was treated with VEXOL (4 Gtt Qd Opht) (View Vexol Review and Vexol Label ), ZYMAR (View Zymar Review and Zymar Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5274948-2 | Erythema, Eye Swelling, Pruritus, Skin Exfoliation
on Oct 26, 2006 Female patient from UNITED STATES , 70 years of age, was diagnosed with prophylaxis and was treated with Nevanac (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, eye swelling, pruritus, skin exfoliation. Nevanac dosage: . During the same period patient was treated with VIGAMOX (View Vigamox Review and Vigamox Label ), ECONOPRED PLUS (View Econopred Plus Review and Econopred Plus Label ), IMDUR (View Imdur Review and Imdur Label ), XANAX (View Xanax Review and Xanax Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5244925-6 | Eye Discharge
Patient was taking Nevanac (View Usage). Patient had the following side effects: eye discharge on Feb 21, 2007 from UNITED STATES Additional patient health information: Female patient , 80 years of age, weighting 124.0 lb, was diagnosed with inflammation and. Nevanac dosage: 0.1% 3 Times Day.